<p>保健美容公司 <strong>如新企业</strong>(NUS -3.17%) 的股票在上周最后一个交易日看起来并不那么新鲜美丽。随着公司发布第二季度业绩，股价当天下跌超过 3%。整体股市表现良好，<strong>标普 500 指数</strong> 录得将近 0.5% 的涨幅。</p>
<h2>揭示第二季度业绩</h2>
<p>周四收盘后不久，如新公布了其第二季度数据。其中最重要的是营收，同比下降 12%，略高于 4.39 亿美元。非通用会计准则（Non-GAAP）调整后的净收入下降更为严重，从 2023 年第二季度的近 2700 万美元跌至 1040 万美元（每股 0.21 美元）。</p>
<p>尽管营收和净利润双双下滑，但如新的主要财务数据明显超出了分析师的一致预期。平均而言，跟踪该股票的预测者们预计营收略低于 4.32 亿美元，调整后每股收益为 0.17 美元。</p>
<p>管理层对业绩进行了正面解读，援引首席执行官 Ryan Napierski 的话称：“在我们的核心如新业务继续应对宏观经济环境的同时，我们鼓舞于包括美国和大部分东南亚/太平洋地区在内的多个市场的顺序增长。”</p>
<p>Napierski 还指出，其战略投资部门 Rhyz 在该期间业务增长了 32%。总体而言，该部门第二季度带来了近 6800 万美元的收入。</p>
<h2>季度盈利指引不及预期</h2>
<p>然而，投资者更关心股票的未来而非最近的过去。如新提供了其当前（第三）季度以及整个 2024 年的指引。</p>
<p>对于前者，公司预计营收为 4.3 亿至 4.65 亿美元，调整后每股收益为 0.15 至 0.25 美元。尽管分析师集体预计的接近 4.6 亿美元营收在给定范围内，但每股 0.42 美元的调整后净收入预测并不在范围内。</p>
<p>至于整个 2024 年，如新预计营收为 17.3 亿至 18.1 亿美元，调整后每股净收入为 0.75 至 0.95 美元。</p>

软银(ADR)

软银

<p>诺丝企业股价在发布第二季度业绩后下跌超过 3%，显示营收下降 12%，调整后净收入显著下滑。尽管超过分析师预期，投资者对公司未来表示担忧。诺丝提供了第三季度和 2024 年的指引，但预测的调整后净收入低于预期。首席执行官 Ryan Napierski 强调了某些市场的增长和公司战略投资部门的成功</p>

<p>The stock of wellness and beauty company <strong>Nu Skin Enterprises</strong>(NUS -3.17%) wasn't looking particularly fresh and beautiful on the last trading day of the week. The shares lost over 3% of their value on the day, following the company's release of its second-quarter results. The rest of the stock market generally did better, with the <strong>S&amp;P 500</strong> index recording a gain of just under 0.5%.</p>
<div class="lb-trans"><p>保健美容公司 <strong>如新企业</strong>(NUS -3.17%) 的股票在上周最后一个交易日看起来并不那么新鲜美丽。随着公司发布第二季度业绩，股价当天下跌超过 3%。整体股市表现良好，<strong>标普 500 指数</strong> 录得将近 0.5% 的涨幅。</p>
</div><h2>Second-quarter results unveiled</h2>
<div class="lb-trans"><h2>揭示第二季度业绩</h2>
</div><p>Shortly after market close on Thursday, Nu Skin published its second-quarter numbers. Chief among these was revenue, which fell by 12% year over year to slightly over $439 million. Non-GAAP (generally accepted accounting principles) adjusted net income suffered a steeper fall, tumbling to $10.4 million ($0.21 per share) from the second-quarter 2023 profit of nearly $27 million.</p>
<div class="lb-trans"><p>周四收盘后不久，如新公布了其第二季度数据。其中最重要的是营收，同比下降 12%，略高于 4.39 亿美元。非通用会计准则（Non-GAAP）调整后的净收入下降更为严重，从 2023 年第二季度的近 2700 万美元跌至 1040 万美元（每股 0.21 美元）。</p>
</div><p>Despite the top- and bottom-line erosion, Nu Skin's headline figures came in comfortably ahead of the consensus analyst estimates. On average, prognosticators following the stock were modeling revenue just shy of $432 million, and adjusted, per-share earnings of $0.17.</p>
<div class="lb-trans"><p>尽管营收和净利润双双下滑，但如新的主要财务数据明显超出了分析师的一致预期。平均而言，跟踪该股票的预测者们预计营收略低于 4.32 亿美元，调整后每股收益为 0.17 美元。</p>
</div><p>Management put a positive spin on its performance, quoting CEO Ryan Napierski as saying, &#34;As our core Nu Skin business continues to navigate the macroeconomic environment, we were encouraged by sequential gains in several of our markets, including the U.S. and most of Southeast Asia/Pacific.&#34;</p>
<div class="lb-trans"><p>管理层对业绩进行了正面解读，援引首席执行官 Ryan Napierski 的话称：“在我们的核心如新业务继续应对宏观经济环境的同时，我们鼓舞于包括美国和大部分东南亚/太平洋地区在内的多个市场的顺序增长。”</p>
</div><p>Napierski also pointed out that Rhyz, its strategic investment arm, saw its business grow by 32% during the period. All told, the unit brought in nearly $68 million in the second quarter.</p>
<div class="lb-trans"><p>Napierski 还指出，其战略投资部门 Rhyz 在该期间业务增长了 32%。总体而言，该部门第二季度带来了近 6800 万美元的收入。</p>
</div><h2>Quarterly earnings guidance falls short</h2>
<div class="lb-trans"><h2>季度盈利指引不及预期</h2>
</div><p>As ever, though, investors are more concerned about a stock's future than its recent past. Nu Skin proffered guidance for both its current (third) quarter, and the entirety of 2024.</p>
<div class="lb-trans"><p>然而，投资者更关心股票的未来而非最近的过去。如新提供了其当前（第三）季度以及整个 2024 年的指引。</p>
</div><p>For the former period, it's expecting $430 million to $465 million in revenue, and adjusted, per-share earnings of $0.15 to $0.25. While the collective analyst top-line estimate of almost $460 million falls within the given range, the $0.42-per-share adjusted net income forecast does not.</p>
<div class="lb-trans"><p>对于前者，公司预计营收为 4.3 亿至 4.65 亿美元，调整后每股收益为 0.15 至 0.25 美元。尽管分析师集体预计的接近 4.6 亿美元营收在给定范围内，但每股 0.42 美元的调整后净收入预测并不在范围内。</p>
</div><p>As for the entirety of 2024, Nu Skin is anticipating $1.73 billion to $1.81 billion, and $0.75 to $0.95 per share for adjusted net income.</p>
<div class="lb-trans"><p>至于整个 2024 年，如新预计营收为 17.3 亿至 18.1 亿美元，调整后每股净收入为 0.75 至 0.95 美元。</p>
</div>

为什么 Nu Skin Enterprises 的股票在周五大跌